Fevipiprant

Min.Order / FOB Price:Get Latest Price

1 Milligram	Negotiable

1 Milligram

Negotiable

Product Details
Company Profile

Min.Order :1 Milligram
Purity: 98% by HPLC

Keywords

Fevipiprant high purity NVP-QAW039;Fevipiprant(NVP-QAW039);QAW039;Fevipiprant (QAW039)

Quick Details

Appearance:light yellow
Application:for lab use only
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:
Transportation:

Superiority:

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonistof the prostaglandin D2 receptor 2 (DP2 or CRTh2)

As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]

Novartis is developing fevipiprant, a prostaglandin D2 receptor (PD2/CRTh2) antagonist, as an oral capsule formulation for treating asthma and moderate to severe atopic dermatitis.

View All